They are starting to take shape Driver line-up who will take to the track in the prossima season of the preparatory category. After the Danish driver Noah Stromsted, Trident has announced who else will join him at the helm in F3: It is Rafael Camara.
From karts to first engagement with Prema
Rafael Chaves Camara was born on May 5, 2005 in Recife, Brazil. He began his Karting career in 2011, taking part in the Pernambuco State Championship. After winning the title in all the national and regional championships, Rafael begins his adventure in international competitions. In 2019 conquer the Second place in the World Karting Championship, driving for the Forza Racing team in the OK Junior category.
In his first year of Senior Karting, he arrives fifth in the European Championship. The year that marks the end of the Brazilian driver's career on karts is 2021. Camara vince in its final season numerous series, such as the WSK Champions Cup, WSK Super Master Series and also becomes vice-champion in the European Championship.

THEdebut of Camara on board a single-seater takes place in 2022. In fact, with the Prema Racing team he took part in the UAE F4 Championship. Rafael collects several victories and podiums, thus putting himself in line for the title fight in the final round. Despite winning Race 1 at Yas Marina, his retirement due to a touch in the third race of the weekend costs him the title, which is thus assigned to Charlie Wurz.
The climb to victory in the FRECA Championship
During the same year he competed in the Italian F4 and ADAC championships. Ferrari Driver Academy driver makes promising start of German series. Two second places and the Race 3 victory at Spa-Francorchamps allows him to grab the lead of the standings. The Brazilian manages to impose himself with a couple of podiums at Hockenheim and Zandvoort, earning the title of challenger to the favorite for the victory Antonelli. At the following round at the Nurburgring, Camara contracts Covid-19, which forces him to miss the event. Rafael Camara gets Rookie title, ending third in the general classification.
In Italian F4 Instead, Camara experienced a competitive start, inheriting the victory in the opening round at Imola. The Brazilian subsequently took the victory at Misano, managing to overtake his teammate at the Safety Car restart. He managed to get on the podium at Spa, Vallelunga and the Red Bull Ring, but missed out on a top-three finish – for the first time in this championship – at the Monza weekend. Rafael Camara takes third place in the standings at the end of the season.

In 2023 Camara, the driver that Trident has chosen to occupy one of the seats F3, Has competed in Formula Regional Middle East with Mumbai Falcons. Despite not winning any races, the young FDA player achieved six podiums, which allowed him to win the third place. In the same year he remained with Prema, but was promoted to the championship European Regional Formula alongside Antonelli and Fluxá. In 2024 Camara remains with the Vicenza team for run in FRECA. On September 29th, Rafael wins the drivers' championship title while Prema wins the constructors' championship.
Rafael Camara to drive for Trident in 2025 FIA F3 season
The Brazilian driver, on the occasion of the announcement of his promotion, said: “I'm so excited to be joining Trident, it's a fabulous team and it's great to be a part of it. I can't wait to start working with everyone and see what we can achieve. Of course the expectations are high, but I think the next one year We will certainly aim to fight for the championship". He continued: "I know it won't be easy, we will have to work hard because it's not only a new car but also a new team for me.".
Giacomo Ricci, Team Manager of the Milanese team declared:”We are proud and happy to announce that Rafael Camara will be part of our driver line-up for the 2025 season. He is a driver undoubtedly talented, Reigning champion of the FRECA category, as well as a driver of the Scuderia Ferrari Driver Academy and we are happy to have him among us. We are also happy to renew our relationship with the FDA program and its drivers".